| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |